Erectile Dysfunction: Causes, Impact & Evidence-Based Treatments

Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It affects ~30–50% of men 40–70, increasing with age and comorbidity.

Pathophysiology (Simplified)

Erection = neurovascular event: Sexual stimulation → NO release → cGMP ↑ → smooth muscle relaxation → arterial inflow ↑ + venous occlusion (tunica albuginea) → rigidity. **Any disruption** along this pathway causes ED.

Major Etiologies

CategoryExamplesMechanism
Vascular (70%)Atherosclerosis, HTN, dyslipidemia, smoking, PADImpaired arterial inflow / veno-occlusive dysfunction
NeurogenicDiabetic neuropathy, spinal cord injury, MS, Parkinson’s, pelvic surgery (RP), radiationInterrupted efferent/afferent signals
HormonalLow T, hyperprolactinemia, thyroid disorders↓ Libido, impaired NO synthase
Medication-inducedSSRIs, β-blockers, thiazides, 5-ARIs, antiandrogens, opioidsMultiple mechanisms
PsychogenicPerformance anxiety, depression, relationship conflict, pornography-associatedCortical inhibition of spinal centers
StructuralPeyronie’s disease, pelvic trauma, fibrosisMechanical impairment

Impact Beyond Sexual Function

  • Cardiovascular sentinel: ED precedes CAD/MI by 3–5 years (endothelial dysfunction shared).
  • Psychosocial: Depression, anxiety, low self-esteem, relationship strain.
  • Quality of life: Comparable to angina, COPD in utility studies.

Stepwise Management

  1. Lifestyle: Weight loss, exercise, smoking cessation, Mediterranean diet, limit alcohol.
  2. Oral PDE5 inhibitors: Sildenafil, tadalafil, vardenafil, avanafil — 60–70% response. Contraindicated with nitrates.
  3. Second-line: Vacuum erection device, intraurethral alprostadil (MUSE), penile injections (alprostadil, bimix, trimix).
  4. Third-line: Penile prosthesis (inflatable 3-piece — gold standard for durability/satisfaction).
  5. Testosterone: Only if hypogonadal (symptoms + low T on 2 AM draws).
  6. Psychosexual therapy: CBT, sensate focus, couples counseling.

When to See a Urologist

  • ED >3 months, or earlier if cardiovascular risk factors present.
  • Desire for non-oral options.
  • Complex comorbidities (post-RP, Peyronie’s, hypogonadism).

ED is a **window into vascular health**. Evaluation should include lipid panel, HbA1c, BP, testosterone, and cardiovascular risk assessment.

Urinary Disorders - Related Articles